New research shows that excess weight increases the risk that a benign blood disorder will progress into multiple myeloma, a cancer of the blood. The study, by a team at Washington University School of Medicine in St. Louis, is published Nov….
Turning Back the Aging Clock
Researchers from Caltech and UCLA have developed a new approach targeting Aging Mitochondrial DNA to remove cellular damage that accumulates with age. Led by Nikolay Kandul, senior postdoctoral scholar in biology and biological engineering in the laboratory of Professor of Biology…
Colombian Pharmaceutical Market to See Strong Four Year Growth
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report states that this substantial…
Phase II-III Services- South America
FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by concentrating on…
Microcapsule Eliminates Toxic Punch of Experimental Anti-Cancer Drug
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue. The encapsulated…
New Mouse Model May Open Autism Treatment Avenues
The hallmark of an excellent researcher is an open mind. That flexibility and openness is what led Nina Schor, the William H. Eilinger Chair of Pediatrics at the University of Rochester, to follow a hunch about a brain receptor– resulting in…
New Brain Protein Tied to Alzheimer’s Disease
Scientists have linked a new protein to Alzheimer’s disease, different from the amyloid and tau that make up the sticky brain plaques and tangles long known to be its hallmarks. The discovery could give a new target for developing drugs and…
Research Shows Cannabis Compound Could Slow Tumor Growth
Scientists at the University of East Anglia have shown how the main psychoactive ingredient in cannabis could reduce tumor growth in cancer patients. Research reveals the existence of previously unknown signaling platforms which are responsible for the drug’s success in shrinking tumors….
Gene’s Role in Diabetes Revealed in Research
New research described details of how a diabetes-related gene functions on a biological pathway that affects the release of insulin. The study authors say that finding drugs that act on that pathway may eventually lead to a new treatment for type…